This article is more than 5 years old. Information may no longer be current.
ARVO and Pfizer Ophthalmics announce joint research institute
Click Here to Manage Email Alerts
FORT LAUDERDALE, Fla. — The Association for Research in Vision and Ophthalmology will partner with Pfizer Ophthalmics, following a $500,000 grant from the company, to create the ARVO/Pfizer Ophthalmics Research Institute, a think tank for vision research. The partnership was announced here at ARVO’s annual meeting.
The ARVO/Pfizer Ophthalmics Research Institute will organize an intensive 2-day conference each year before the annual meeting here that will bring together experts in the fields of basic science, ophthalmology, genetics, bioengineering and other specialties to collaborate on vision research, with a focus on glaucoma and retinal disease.
The invitation-only conferences, to begin in 2005, will be open to ARVO members and key representatives from other scientific disciplines.
The grant will promote “interdisciplinary work among a small group of the brightest minds whose research in this large scientific area will have a global reach,” said Paul Kaufman, MD, executive vice president of ARVO, in a press release. The conferences will help to bridge the gap between research in ophthalmology and in other fields of medicine.
The grant will also fund the ARVO/Pfizer Ophthalmics Translational Research Awards. These awards, to be presented at each annual ARVO meeting, will honor ARVO scientists who exhibit excellence in “translational” research — basic research with clinical applications.